REVOLADE Novartis Pharmaceuticals Australia Pty Ltd

Revolade 25mg Tablet Revolade 25mg Tablet is used to treat low platelet count due to chronic immune thrombocytopenic purpura

Revolade medicine 50mg has the main active ingredient Eltrombopag in the form of Eltrombopag olamine with a strength of 50mg Revolade medicine 50mg is used

revolade Revolade pCPA File Number: 20760 Negotiation Status: Negotiations were not pursued Indication: Thrombocytopenia associated

revolade REVOLADE GLAXOSMITHKLINE Click on a Brand to view Alternate Brands of same Drug dosage Retail Rs REVOLADE, [